{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T01:23:04Z","timestamp":1781227384377,"version":"3.54.1"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:00:00Z","timestamp":1760832000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012728","name":"National Cancer Institute Frederick National Laboratory for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012728","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["75N91019D00024"],"award-info":[{"award-number":["75N91019D00024"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["slas-discovery.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["SLAS Discovery"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.slasd.2025.100284","type":"journal-article","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:38:14Z","timestamp":1761129494000},"page":"100284","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["High-throughput combination screening of Pidnarulex and other G-quadruplex ligands in multi-cell type tumor spheroids"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6444-3121","authenticated-orcid":false,"given":"Thomas S.","family":"Dexheimer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan P.","family":"Coussens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Silvers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poorva","family":"Juneja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven D.","family":"Gore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W.","family":"Kunkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4463-1790","authenticated-orcid":false,"given":"James H.","family":"Doroshow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly A.","family":"Teicher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.slasd.2025.100284_bib0001","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.1093\/nar\/gkl655","article-title":"Quadruplex DNA: sequence, topology and structure","volume":"34","author":"Burge","year":"2006","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.slasd.2025.100284_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-9666-7_1","article-title":"G-quadruplex DNA and RNA","volume":"2035","author":"Yang","year":"2019","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.slasd.2025.100284_bib0003","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1261\/rna.078238.120","article-title":"The emerging structural complexity of G-quadruplex RNAs","volume":"27","author":"Banco","year":"2021","journal-title":"RNa"},{"key":"10.1016\/j.slasd.2025.100284_bib0004","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nchem.1548","article-title":"Quantitative visualization of DNA G-quadruplex structures in human cells","volume":"5","author":"Biffi","year":"2013","journal-title":"Nat Chem"},{"key":"10.1016\/j.slasd.2025.100284_bib0005","article-title":"Single-cell mapping of DNA G-quadruplex structures in human cancer cells","volume":"11","author":"Hui","year":"2021","journal-title":"Sci Rep-Uk"},{"key":"10.1016\/j.slasd.2025.100284_bib0006","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/s41588-023-01437-4","article-title":"G4access identifies G-quadruplexes and their associations with open chromatin and imprinting control regions","volume":"55","author":"Esnault","year":"2023","journal-title":"Nat Genet"},{"key":"10.1016\/j.slasd.2025.100284_bib0007","first-page":"10","article-title":"Involvement of G-quadruplex regions in mammalian replication origin activity","author":"Prorok","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.slasd.2025.100284_bib0008","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bbrc.2020.05.132","article-title":"G-quadruplex DNA and RNA: their roles in regulation of DNA replication and other biological functions","volume":"531","author":"Masai","year":"2020","journal-title":"Biochem Bioph Res Co"},{"key":"10.1016\/j.slasd.2025.100284_bib0009","doi-asserted-by":"crossref","first-page":"8419","DOI":"10.1093\/nar\/gkab609","article-title":"DNA G-quadruplex structures: more than simple roadblocks to transcription?","volume":"49","author":"Robinson","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.slasd.2025.100284_bib0010","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-30071-7","article-title":"Alternative splicing modulation by G-quadruplexes","volume":"13","author":"Georgakopoulos-Soares","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.slasd.2025.100284_bib0011","doi-asserted-by":"crossref","DOI":"10.1080\/21690731.2016.1244031","article-title":"RNA G-quadruplexes and their potential regulatory roles in translation","volume":"4","author":"Song","year":"2016","journal-title":"Translation"},{"key":"10.1016\/j.slasd.2025.100284_bib0012","article-title":"Impact of G-quadruplexes on the regulation of genome integrity","volume":"11","author":"Pavlova","year":"2021","journal-title":"DNA Damage Repair Biomol"},{"key":"10.1016\/j.slasd.2025.100284_bib0013","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/nar\/gkl1057","article-title":"G-quadruplexes in promoters throughout the human genome","volume":"35","author":"Huppert","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.slasd.2025.100284_bib0014","doi-asserted-by":"crossref","first-page":"6260","DOI":"10.1093\/nar\/gkn511","article-title":"G-quadruplexes: the beginning and end of UTRs","volume":"36","author":"Huppert","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.slasd.2025.100284_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122481","article-title":"G-quadruplex ligands in cancer therapy: progress, challenges, and clinical perspectives","volume":"340","author":"Figueiredo","year":"2024","journal-title":"Life Sci"},{"key":"10.1016\/j.slasd.2025.100284_bib0016","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd3428","article-title":"Targeting G-quadruplexes in gene promoters: a novel anticancer strategy?","volume":"10","author":"Balasubramanian","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.slasd.2025.100284_bib0017","doi-asserted-by":"crossref","DOI":"10.1038\/s41570-017-0041","article-title":"Quadruplex nucleic acids as targets for anticancer therapeutics","volume":"1","author":"Neidle","year":"2017","journal-title":"Nat Rev Chem"},{"key":"10.1016\/j.slasd.2025.100284_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.129016","article-title":"A first-in-class clinical G-quadruplex-targeting drug. The bench-to-bedside translation of the fluoroquinolone QQ58 to CX-5461 (Pidnarulex)","volume":"77","author":"Xu","year":"2022","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.slasd.2025.100284_bib0019","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1021\/ml300110s","article-title":"Discovery of CX-5461, the first direct and selective inhibitor of RNA polymerase I, for Cancer Therapeutics","volume":"3","author":"Haddach","year":"2012","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.slasd.2025.100284_bib0020","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1158\/0008-5472.CAN-10-1728","article-title":"Targeting RNA polymerase I with an oral small molecule CX-5461 inhibits ribosomal RNA synthesis and solid tumor growth","volume":"71","author":"Drygin","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.slasd.2025.100284_bib0021","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1073\/pnas.1921649117","article-title":"The primary mechanism of cytotoxicity of the chemotherapeutic agent CX-5461 is topoisomerase II poisoning","volume":"117","author":"Bruno","year":"2020","journal-title":"P Natl Acad Sci USA"},{"key":"10.1016\/j.slasd.2025.100284_bib0022","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41580-020-0236-x","article-title":"The regulation and functions of DNA and RNA G-quadruplexes","volume":"21","author":"Varshney","year":"2020","journal-title":"Nat Rev Mol Cell Bio"},{"key":"10.1016\/j.slasd.2025.100284_bib0023","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.65184","article-title":"Transcription-associated topoisomerase 2\u03b1 a (TOP2A) activity is a major effector of cytotoxicity induced by G-quadruplex ligands","volume":"10","author":"Bossaert","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.slasd.2025.100284_bib0024","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-26640-x","article-title":"The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastoma","volume":"12","author":"Pan","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.slasd.2025.100284_bib0025","first-page":"103","article-title":"Design and synthesis of fluoroquinophenoxazines that interact with human telomeric G-quadruplexes and their biological effects","volume":"1","author":"Duan","year":"2001","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.slasd.2025.100284_bib0026","article-title":"CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1\/2 deficient tumours","volume":"8","author":"Xu","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.slasd.2025.100284_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2023.129384","article-title":"A synthetic lethal approach to drug targeting of G-quadruplexes based on CX-5461","volume":"91","author":"Jin","year":"2023","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.slasd.2025.100284_bib0028","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41588-023-01602-9","article-title":"The chemotherapeutic drug CX-5461 is a potent mutagen in cultured human cells","volume":"56","author":"Koh","year":"2024","journal-title":"Nat Genet"},{"key":"10.1016\/j.slasd.2025.100284_bib0029","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1158\/1535-7163.MCT-17-1209","article-title":"APTO-253 stabilizes G-quadruplex DNA, inhibits MYC expression, and induces DNA damage in acute myeloid leukemia cells","volume":"17","author":"Local","year":"2018","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.slasd.2025.100284_bib0030","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1158\/1535-7163.MCT-17-0834","article-title":"APTO-253 is a new addition to the repertoire of drugs that can exploit DNA BRCA1\/2 deficiency","volume":"17","author":"Tsai","year":"2018","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.slasd.2025.100284_bib0031","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.1073\/pnas.081560598","article-title":"Structure-based design of selective and potent G quadruplex-mediated telomerase inhibitors","volume":"98","author":"Read","year":"2001","journal-title":"Proc Natl Acad Sci u S a"},{"key":"10.1016\/j.slasd.2025.100284_bib0032","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1158\/0008-5472.CAN-04-2910","article-title":"The G-quadruplex-interactive molecule BRACO-19 inhibits tumor growth, consistent with telomere targeting and interference with telomerase function","volume":"65","author":"Burger","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.slasd.2025.100284_bib0033","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1177\/24725552211038362","article-title":"Complex tumor spheroids, a tissue-mimicking tumor model, for drug discovery and precision medicine","volume":"26","author":"Kaur","year":"2021","journal-title":"SLAS Discov"},{"key":"10.1016\/j.slasd.2025.100284_bib0034","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1158\/2767-9764.CRC-23-0193","article-title":"Multicellular complex tumor spheroid response to DNA repair inhibitors in combination with DNA-damaging drugs","volume":"3","author":"Dexheimer","year":"2023","journal-title":"Cancer Res Commun"},{"key":"10.1016\/j.slasd.2025.100284_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.slasd.2024.100186","article-title":"Combination screen in multi-cell type tumor spheroids reveals interaction between aryl hydrocarbon receptor antagonists and E1 ubiquitin-activating enzyme inhibitor","volume":"29","author":"Dexheimer","year":"2024","journal-title":"SLAS Discov"},{"key":"10.1016\/j.slasd.2025.100284_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.slasd.2025.100230","article-title":"Combinatorial screen with apoptosis pathway targeted agents alrizomadlin, pelcitoclax, and dasminapant in multi-cell type tumor spheroids","volume":"33","author":"Coussens","year":"2025","journal-title":"SLAS Discov"},{"key":"10.1016\/j.slasd.2025.100284_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.slasd.2025.100222","article-title":"Combinatorial screen of targeted agents with the PI3K inhibitors inavolisib, alpelisib, duvelisib, and copanlisib in multi-cell type tumor spheroids","volume":"32","author":"Dexheimer","year":"2025","journal-title":"SLAS Discov"},{"key":"10.1016\/j.slasd.2025.100284_bib0038","doi-asserted-by":"crossref","DOI":"10.1158\/1538-7445.AM2023-4884","article-title":"Targeted investigational oncology agents (IOA) in the NCI60: a phenotypic systems-based resource","volume":"83","author":"Morris","year":"2023","journal-title":"Cancer Res"},{"key":"10.1016\/j.slasd.2025.100284_bib0039","unstructured":"Iversen PW BB, Chen YF, Dere W, Devanarayan V, Eastwood BJ, et al. HTS Assay Validation. In: Markossian S, Grossman A, Arkin M, Auld D, Austin C, Baell J, et al., editors. Assay Guidance Manual. Bethesda (MD) 2004."},{"key":"10.1016\/j.slasd.2025.100284_bib0040","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J Biomol Screen"},{"key":"10.1016\/j.slasd.2025.100284_bib0041","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1744-7348.1939.tb06990.x","article-title":"The toxicity of poisons applied jointly","volume":"26","author":"Bliss","year":"1939","journal-title":"Ann Appl Biol"},{"key":"10.1016\/j.slasd.2025.100284_bib0042","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1158\/0008-5472.CAN-23-3031","article-title":"HTS384 NCI60: The next phase of the NCI60 screen","volume":"84","author":"Kunkel","year":"2024","journal-title":"Cancer Res"},{"key":"10.1016\/j.slasd.2025.100284_bib0043","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1093\/jnci\/81.14.1088","article-title":"Display and analysis of patterns of differential activity of drugs against Human-tumor cell-lines - development of mean graph and compare algorithm","volume":"81","author":"Paull","year":"1989","journal-title":"Jnci-J Natl Cancer I"},{"key":"10.1016\/j.slasd.2025.100284_bib0044","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.molcel.2015.12.004","article-title":"Targeting BRCA1 and BRCA2 deficiencies with G-quadruplex-interacting compounds","volume":"61","author":"Zimmer","year":"2016","journal-title":"Mol Cell"},{"key":"10.1016\/j.slasd.2025.100284_bib0045","doi-asserted-by":"crossref","first-page":"14925","DOI":"10.18632\/oncotarget.7483","article-title":"Telomere targeting with a novel G-quadruplex-interactive ligand BRACO-19 induces T-loop disassembly and telomerase displacement in human glioblastoma cells","volume":"7","author":"Zhou","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.slasd.2025.100284_bib0046","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaf543","article-title":"Pyridine-bis(benzimidazole) induces DNA damage at G-quadruplex loci and promotes synthetic lethality with DNA repair inhibition","volume":"53","author":"Yan","year":"2025","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.slasd.2025.100284_bib0047","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.18632\/aging.101282","article-title":"The G-quadruplex DNA stabilizing drug pyridostatin promotes DNA damage and downregulates transcription of Brca1 in neurons","volume":"9","author":"Moruno-Manchon","year":"2017","journal-title":"Aging-Us"},{"key":"10.1016\/j.slasd.2025.100284_bib0048","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41575-020-0300-1","article-title":"Pancreatic cancer stroma: an update on therapeutic targeting strategies","volume":"17","author":"Hosein","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.slasd.2025.100284_bib0049","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41568-020-00329-7","article-title":"The matrix in cancer","volume":"21","author":"Cox","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.slasd.2025.100284_bib0050","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-16393-4","article-title":"CX-5461 activates the DNA damage response and demonstrates therapeutic efficacy in high-grade serous ovarian cancer","volume":"11","author":"Sanij","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.slasd.2025.100284_bib0051","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1158\/1535-7163.MCT-20-0932","article-title":"CX-5461 sensitizes DNA damage repair-proficient castrate-resistant prostate cancer to PARP inhibition","volume":"20","author":"Lawrence","year":"2021","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.slasd.2025.100284_bib0052","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nchembio.780","article-title":"Small-molecule-induced DNA damage identifies alternative DNA structures in human genes","volume":"8","author":"Rodriguez","year":"2012","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.slasd.2025.100284_bib0053","doi-asserted-by":"crossref","first-page":"9640","DOI":"10.1021\/ja404868t","article-title":"G-quadruplex DNA as a molecular target for induced synthetic lethality in cancer cells","volume":"135","author":"McLuckie","year":"2013","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.slasd.2025.100284_bib0054","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202114501","article-title":"Anti-tumoural activity of the G-quadruplex ligand pyridostatin against BRCA1\/2-deficient tumours","volume":"14","author":"Groelly","year":"2022","journal-title":"EMBo Mol Med"},{"key":"10.1016\/j.slasd.2025.100284_bib0055","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.46793","article-title":"Genetic interactions of G-quadruplexes in humans","volume":"8","author":"Zyner","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.slasd.2025.100284_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104710","article-title":"WEE1 inhibition in cancer therapy: mechanisms, synergies, preclinical insights, and clinical trials","volume":"211","author":"Thangaretnam","year":"2025","journal-title":"Crit Rev Oncol Hemat"},{"key":"10.1016\/j.slasd.2025.100284_bib0057","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.828684","article-title":"Targeting the DNA damage response for cancer therapy by inhibiting the kinase Wee1","volume":"12","author":"Bukhari","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.slasd.2025.100284_bib0058","article-title":"A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target","volume":"13","author":"di Ror\u00e0","year":"2020","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.slasd.2025.100284_bib0059","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.132030","article-title":"A review on structure-function mechanism and signaling pathway of serine\/threonine protein PIM kinases as a therapeutic target","volume":"270","author":"Rout","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.slasd.2025.100284_bib0060","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1093\/hmg\/10.12.1287","article-title":"Evidence for BLM and Topoisomerase iii\u03b1 interaction in genomic stability","volume":"10","author":"Hu","year":"2001","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.slasd.2025.100284_bib0061","doi-asserted-by":"crossref","first-page":"9636","DOI":"10.1074\/jbc.275.13.9636","article-title":"The Bloom's syndrome gene product interacts with topoisomerase III","volume":"275","author":"Wu","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.slasd.2025.100284_bib0062","article-title":"The G-quadruplex ligand CX-5461: an innovative candidate for disease treatment","volume":"23","author":"Li","year":"2025","journal-title":"J Transl Med"},{"key":"10.1016\/j.slasd.2025.100284_bib0063","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/nature02253","article-title":"The Bloom's syndrome helicase suppresses crossing over during homologous recombination","volume":"426","author":"Wu","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.slasd.2025.100284_bib0064","doi-asserted-by":"crossref","first-page":"31484","DOI":"10.1074\/jbc.M706116200","article-title":"Holliday junction processing activity of the BLM-topo iii\u03b1-BLAP75 complex","volume":"282","author":"Bussen","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.slasd.2025.100284_bib0065","doi-asserted-by":"crossref","first-page":"21426","DOI":"10.1074\/jbc.M110.123216","article-title":"Human topoisomerase iii\u03b1 is a single-stranded DNA decatenase that is stimulated by BLM and RMI1","volume":"285","author":"Yang","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.slasd.2025.100284_bib0066","doi-asserted-by":"crossref","first-page":"11083","DOI":"10.1093\/nar\/gku803","article-title":"Multifaceted role of the topo iii\u03b1-RMI1-RMI2 complex and DNA2 in the BLM-dependent pathway of DNA break end resection","volume":"42","author":"Daley","year":"2014","journal-title":"Nucleic Acids Res"}],"container-title":["SLAS Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472555225000772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472555225000772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T16:34:02Z","timestamp":1764866042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2472555225000772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":66,"alternative-id":["S2472555225000772"],"URL":"https:\/\/doi.org\/10.1016\/j.slasd.2025.100284","relation":{},"ISSN":["2472-5552"],"issn-type":[{"value":"2472-5552","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-throughput combination screening of Pidnarulex and other G-quadruplex ligands in multi-cell type tumor spheroids","name":"articletitle","label":"Article Title"},{"value":"SLAS Discovery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.slasd.2025.100284","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of Society for Laboratory Automation and Screening.","name":"copyright","label":"Copyright"}],"article-number":"100284"}}